BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 23247231)

  • 41. Superselective intra-arterial chemoradiation therapy for functional laryngeal preservation in advanced squamous cell carcinoma of the glottic larynx.
    Furusaka T; Matsuda A; Tanaka A; Matsuda H; Ikeda M
    Acta Otolaryngol; 2013 Jun; 133(6):633-40. PubMed ID: 23394224
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Survival Rates Using Individualized Bioselection Treatment Methods in Patients With Advanced Laryngeal Cancer.
    Wolf GT; Bellile E; Eisbruch A; Urba S; Bradford CR; Peterson L; Prince ME; Teknos TN; Chepeha DB; Hogikyan ND; McLean SA; Moyer J; Taylor JMG; Worden FP
    JAMA Otolaryngol Head Neck Surg; 2017 Apr; 143(4):355-366. PubMed ID: 28152117
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term observations and salvage operations on patients with T2N0M0 squamous cell carcinoma of the glottic larynx treated with radiation therapy alone.
    Furusaka T; Matuda H; Saito T; Katsura Y; Ikeda M
    Acta Otolaryngol; 2012 May; 132(5):546-51. PubMed ID: 22264025
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Results of surgical salvage after failure of definitive radiation therapy for early-stage squamous cell carcinoma of the glottic larynx.
    Ganly I; Patel SG; Matsuo J; Singh B; Kraus DH; Boyle JO; Wong RJ; Shaha AR; Lee N; Shah JP
    Arch Otolaryngol Head Neck Surg; 2006 Jan; 132(1):59-66. PubMed ID: 16415431
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Racial disparities in laryngeal cancer treatment and outcome: A population-based analysis of 24,069 patients.
    Shin JY; Truong MT
    Laryngoscope; 2015 Jul; 125(7):1667-74. PubMed ID: 25694265
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Functional outcomes following treatment for advanced laryngeal cancer. Part I--Voice preservation in advanced laryngeal cancer. Part II--Laryngectomy rehabilitation: the state of the art in the VA System. Research Speech-Language Pathologists. Department of Veterans Affairs Laryngeal Cancer Study Group.
    Hillman RE; Walsh MJ; Wolf GT; Fisher SG; Hong WK
    Ann Otol Rhinol Laryngol Suppl; 1998 May; 172():1-27. PubMed ID: 9597955
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998-2005).
    Chen AY; Halpern MT; Schrag NM; Stewart A; Leitch M; Ward E
    J Natl Cancer Inst; 2008 Apr; 100(7):462-74. PubMed ID: 18364506
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of hospital safety-net burden status on short-term outcomes and cost of care after head and neck cancer surgery.
    Genther DJ; Gourin CG
    Arch Otolaryngol Head Neck Surg; 2012 Nov; 138(11):1015-22. PubMed ID: 23165375
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cost comparison of surgery vs organ preservation for laryngeal cancer.
    Davis GE; Schwartz SR; Veenstra DL; Yueh B
    Arch Otolaryngol Head Neck Surg; 2005 Jan; 131(1):21-6. PubMed ID: 15655180
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm.
    Urba S; Wolf G; Eisbruch A; Worden F; Lee J; Bradford C; Teknos T; Chepeha D; Prince M; Hogikyan N; Taylor J
    J Clin Oncol; 2006 Feb; 24(4):593-8. PubMed ID: 16380415
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparing surgical and nonsurgical larynx-preserving treatments with total laryngectomy for locally advanced laryngeal cancer.
    Patel SA; Qureshi MM; Dyer MA; Jalisi S; Grillone G; Truong MT
    Cancer; 2019 Oct; 125(19):3367-3377. PubMed ID: 31206637
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term follow-up and salvage surgery in patients with T2N0M0 squamous cell carcinoma of the glottic larynx who received concurrent chemoradiation therapy with carboplatin (CBDCA) - AUC 1.5 vs AUC 2.0.
    Furusaka T; Matsuda H; Saito T; Katsura Y; Ikeda M
    Acta Otolaryngol; 2012 Nov; 132(11):1215-23. PubMed ID: 23025385
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oncologic and functional outcomes of partial laryngeal surgery for intermediate-stage laryngeal cancer.
    Caicedo-Granados E; Beswick DM; Christopoulos A; Cunningham DE; Razfar A; Ohr JP; Heron DE; Ferris RL
    Otolaryngol Head Neck Surg; 2013 Feb; 148(2):235-42. PubMed ID: 23131825
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Changes in treatment of advanced laryngeal cancer 1985-2001.
    Chen AY; Schrag N; Hao Y; Flanders WD; Kepner J; Stewart A; Ward E
    Otolaryngol Head Neck Surg; 2006 Dec; 135(6):831-7. PubMed ID: 17141069
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Racial disparities and socioeconomic status in association with survival in a large population-based cohort of elderly patients with colon cancer.
    Du XL; Fang S; Vernon SW; El-Serag H; Shih YT; Davila J; Rasmus ML
    Cancer; 2007 Aug; 110(3):660-9. PubMed ID: 17582625
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Surgeon characteristics and receipt of adjuvant radiotherapy in women with breast cancer.
    Hershman DL; Buono D; McBride RB; Tsai WY; Joseph KA; Grann VR; Jacobson JS
    J Natl Cancer Inst; 2008 Feb; 100(3):199-206. PubMed ID: 18230795
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Salvage surgery after radiotherapy for laryngeal cancer: from endoscopic resections to open-neck partial and total laryngectomies.
    Piazza C; Peretti G; Cattaneo A; Garrubba F; De Zinis LO; Nicolai P
    Arch Otolaryngol Head Neck Surg; 2007 Oct; 133(10):1037-43. PubMed ID: 17938329
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Survival Outcomes for Patients With T3N0M0 Squamous Cell Carcinoma of the Glottic Larynx.
    Ko HC; Harari PM; Chen S; Wieland AM; Yu M; Baschnagel AM; Kimple RJ; Witek ME
    JAMA Otolaryngol Head Neck Surg; 2017 Nov; 143(11):1126-1133. PubMed ID: 29049434
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pretreatment probability model for predicting outcome after intraarterial chemoradiation for advanced head and neck carcinoma.
    van den Broek GB; Rasch CR; Pameijer FA; Peter E; van den Brekel MW; Tan IB; Schornagel JH; de Bois JA; Zijp LJ; Balm AJ
    Cancer; 2004 Oct; 101(8):1809-17. PubMed ID: 15386309
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immune reactivity does not predict chemotherapy response, organ preservation, or survival in advanced laryngeal cancer.
    Wolf GT; Bradford CR; Urba S; Smith A; Eisbruch A; Chepeha DB; Teknos TN; Worden F; Dawson L; Terrell JE; Hogikyan ND
    Laryngoscope; 2002 Aug; 112(8 Pt 1):1351-6. PubMed ID: 12172244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.